Successful Treatment of Pembrolizumab-Induced Severe Capillary Leak Syndrome and Lymphatic Capillary Dysfunction

[1]  Y. Aoyama,et al.  Systemic capillary leak syndrome triggered by anti‐programmed death 1 checkpoint inhibitor in psoriasis , 2020, The Journal of dermatology.

[2]  C. Lescure,et al.  Systemic Capillary Leak Syndrome (Clarkson's Disease) as a Complication of Anti-Programmed Death 1 Immunotherapy. , 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[3]  Stephanie M. Mutchler,et al.  New insights regarding epithelial Na+ channel regulation and its role in the kidney, immune system and vasculature , 2019, Current opinion in nephrology and hypertension.

[4]  A. Koyanagi,et al.  Incidence of Capillary Leak Syndrome as an Adverse Effect of Drugs in Cancer Patients: A Systematic Review and Meta-Analysis , 2019, Journal of clinical medicine.

[5]  P. Lacal,et al.  Therapeutic implication of vascular endothelial growth factor receptor‐1 (VEGFR‐1) targeting in cancer cells and tumor microenvironment by competitive and non‐competitive inhibitors , 2018, Pharmacological research.

[6]  H. Uchi,et al.  Melanoma and Immune Checkpoint Inhibitors , 2018, Current Oncology Reports.

[7]  Matthew D. Hellmann,et al.  Immune‐Related Adverse Events Associated with Immune Checkpoint Blockade , 2018, The New England journal of medicine.

[8]  James R. Anderson,et al.  Durable Complete Response After Discontinuation of Pembrolizumab in Patients With Metastatic Melanoma. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  Marc Lambert,et al.  Intravenous Immunoglobulins Improve Survival in Monoclonal Gammopathy-Associated Systemic Capillary-Leak Syndrome. , 2017, The American journal of medicine.

[10]  B. Souweine,et al.  The Clinical Picture of Severe Systemic Capillary-Leak Syndrome Episodes Requiring ICU Admission , 2017, Critical care medicine.

[11]  D. Fisher,et al.  Immune and molecular correlates in melanoma treated with immune checkpoint blockade , 2017, Cancer.

[12]  S. Mandrekar,et al.  Idiopathic systemic capillary leak syndrome (Clarkson's disease): the Mayo clinic experience. , 2010, Mayo Clinic proceedings.

[13]  S. Kato,et al.  Rapid improvement of life-threatening capillary leak syndrome after stem cell transplantation by bevacizumab. , 2010, Blood.

[14]  T. Chatila,et al.  Idiopathic systemic capillary leak syndrome: novel therapy for acute attacks. , 2009, The Journal of allergy and clinical immunology.

[15]  E. Hachulla,et al.  High-dose intravenous immunoglobulins dramatically reverse systemic capillary leak syndrome , 2008, Critical care medicine.

[16]  B. Clarkson,et al.  Cyclical edema and shock due to increased capillary permeability. , 1960, Transactions of the Association of American Physicians.